cagrisema semaglutide cagrilintide phase 3 results 2024 2025 Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes CagriSema Reduces Blood Pressure in

On paediatric potential, these therapies are currently approved in type 2 diabetes from age 12, and the evidence picture in type 1 diabetes is evolving

Management of the dry ejaculate: a systematic review of aspermia and retrograde ejaculation

Also, some people experience digestive issues when taking semaglutide

Semaglutide also produced clinically meaningful reductions in waist circumference, blood pressure, triglycerides and improved glycaemic control

Close monitoring during treatment is recommended, and medical help should be sought if symptoms like reduced urine output, swelling, or unusual weakness occur

29 Additionally, organoid technology focuses on growing miniature, three-dimensional tissue structures from stem cells that replicate human organs and has become a powerful tool for disease modeling, drug discovery, and precision medicine